Radiosensitization effect of luteolin on human gastric cancer SGC-7901 cells

Journal of Biological Regulators and Homeostatic Agents

Volumn 23, Issue 2, 2009, Pages 71-78

  Zhang, Qiang ^a   Wan, L ^a   Guo, Y ^a   Cheng, N ^a   Cheng, W ^a   Sun, Q ^a   Zhu, J ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Gastric cancer; Luteolin; Radiosensitizer

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; LUTEOLIN; PROTEIN BCL 2; VASCULOTROPIN; CASP3 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROSTAGLANDIN E2; RADIOSENSITIZING AGENT; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; RADIOSENSITIZATION; STOMACH CANCER; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DRUG SCREENING; METABOLISM; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PATHOLOGY; RADIATION EXPOSURE; STOMACH TUMOR; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DINOPROSTONE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUTEOLIN; MICE; MICE, INBRED BALB C; MICE, NUDE; RADIATION-SENSITIZING AGENTS; STOMACH NEOPLASMS; TUMOR STEM CELL ASSAY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73349132407     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 2003; 14(S):ii31-6. (Pubitemid 36874136)
2. Bulanov D. [Gastric cancer - current state of the problem. Part I. Epidemiology. Pathology. Classification. Staging]. Khirurgiia (Sofiia) 2007; 4:48-59.
3. Starzynska T. Molecular epidemiology of gastric cancer. Dig Dis 2007; 25:222-224
4. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 2:354-362
5. Scartozzi M, Galizia E, Verdecchia L, Berardi R, Antognoli S, Chiorrini S, Cascinu S. Chemotherapy for advanced gastric cancer: across the years for a standard of care. Expert Opin Pharmacother 2007; 8:797-808. (Pubitemid 46744768)
6. Schipper DL, Wagener DJ. Chemotherapy of gastric cancer. Anti-cancer Drugs 1996; 7:137-149
7. Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol 2007; 19:97-417.
8. Hosseinimehr SJ, Tavakoli H, Pourheidari G, Sobhani A, Shafiee A. Radioprotective effects of citrus extract against gamma-irradiation in mouse bone marrow cells. J Radiat Res 2003; 44:237-241 (Pubitemid 38738727)
9. Watanabe N, Hirayama R, Kubota N. The chemopreventive flavonoid apigenin confers radiosensitizing effect in human tumor cells grown as monolayers and spheroids. J Radiat Res 2007; 48:45-50. (Pubitemid 46219476)
10. Zhang FF, Shen HM, Zhu XQ. [Research progress on anti-tumor effects of luteolin]. Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University 2006; 35:573-578
11. Pajonk F, Pajonk K, McBride WH. Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells. J Nat Cancer Inst 1999; 91:1956-1960
12. Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005; 7:1630-1647
13. Hamamoto T, Suzuki K, Sasaki H, Ichikawa M, Kodama S, Watanabe M. Differences in effects of oncogenes on sensitivity to anticancer drugs. J Radiat Res 2005; 46:197-203. (Pubitemid 41190656)
14. Wu B, Zhang Q, Shen W, Zhu J. Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem 2008; 313:125-132
15. Gonzalez-Gallego J, Sanchez-Campos S, Tunon MJ. Anti-inflammatory properties of dietary flavonoids. Nutr Hosp 2007; 22:287-293
16. Li Y, Fang H, Xu W. Recent advance in the research of flavonoids as anticancer agents. Mini Rev Med Chem 2007; 7:663-678 (Pubitemid 47099168)
17. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004; 53:153-159
18. Fisher DE. Pathways of apoptosis and the modulation of cell death in cancer. Hematol Oncol Clin North Am 2001; 15:931-956 (Pubitemid 34030525)
19. Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006; 25:4798-4811 (Pubitemid 44187627)
20. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 2004; 5:897-907. (Pubitemid 39486541)
21. Milas L. Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse. Semin Radiat Oncol 2001; 11:290-299 (Pubitemid 32959664)
22. Harada H, Kizaka-Kondoh S, Li G, Itasaka S, Shibuya K, Inoue M, Hiraoka M. Significance of HIF-1-active cells in angiogenesis and radioresistance. Oncogene 2007; 26:7508-7516 (Pubitemid 350207705)